FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033687467> ?p ?o ?g. }

• W2033687467 endingPage "1393" @default.
• W2033687467 startingPage "1390" @default.
• W2033687467 abstract "Data on transcatheter aortic valve implantation (TAVI) for severe bicuspid aortic valve (BAV) stenosis and how this compares to that for tricuspid aortic valve (TAV) stenosis are limited. Twenty-one consecutive patients with BAV were treated with the Edwards or CoreValve bioprosthesis from November 2007 to December 2012 at San Raffaele Scientific Institute and Clinical Institute S. Ambrogio, Milan, Italy. Results were compared with a cohort of patients with TAV (n = 447) treated with the same bioprostheses over the same period. Procedural 1- and 12-month outcomes were examined as defined by the Valve Academic Research Consortium criteria. Patients with BAV were younger (76.7 ± 7.1 vs 79.8 ± 7.4 years, p = 0.06) and with a larger aortic annulus (25.0 ± 1.8 vs 23.6 ± 2.1 mm, p = 0.01). Device success (85.7% vs 94.4%, p = 0.10) was lower in patients with BAV. Although the 30-day composite safety end point (23.8% vs 21.0%, p = 0.76) was similar between the 2 groups, mortality rate at 30 days was higher (14.2% vs 3.6%, p = 0.02) in the BAV group. Cardiovascular mortality at 1 year did not differ significantly between the 2 groups (10.5% vs 7.4%, p = 0.62). In conclusion, transcatheter aortic valve implantation in high surgical risk patients with severe BAV stenosis appears to be feasible with mid-term cardiovascular mortality similar to that for patients with TAV. Early survival and device success, however, were lower for patients with BAV demonstrating that further studies are required to identify which subset of patients with BAV is best suited for transcatheter treatment. Data on transcatheter aortic valve implantation (TAVI) for severe bicuspid aortic valve (BAV) stenosis and how this compares to that for tricuspid aortic valve (TAV) stenosis are limited. Twenty-one consecutive patients with BAV were treated with the Edwards or CoreValve bioprosthesis from November 2007 to December 2012 at San Raffaele Scientific Institute and Clinical Institute S. Ambrogio, Milan, Italy. Results were compared with a cohort of patients with TAV (n = 447) treated with the same bioprostheses over the same period. Procedural 1- and 12-month outcomes were examined as defined by the Valve Academic Research Consortium criteria. Patients with BAV were younger (76.7 ± 7.1 vs 79.8 ± 7.4 years, p = 0.06) and with a larger aortic annulus (25.0 ± 1.8 vs 23.6 ± 2.1 mm, p = 0.01). Device success (85.7% vs 94.4%, p = 0.10) was lower in patients with BAV. Although the 30-day composite safety end point (23.8% vs 21.0%, p = 0.76) was similar between the 2 groups, mortality rate at 30 days was higher (14.2% vs 3.6%, p = 0.02) in the BAV group. Cardiovascular mortality at 1 year did not differ significantly between the 2 groups (10.5% vs 7.4%, p = 0.62). In conclusion, transcatheter aortic valve implantation in high surgical risk patients with severe BAV stenosis appears to be feasible with mid-term cardiovascular mortality similar to that for patients with TAV. Early survival and device success, however, were lower for patients with BAV demonstrating that further studies are required to identify which subset of patients with BAV is best suited for transcatheter treatment." @default.
• W2033687467 created "2016-06-24" @default.
• W2033687467 creator A5023950438 @default.
• W2033687467 creator A5024321268 @default.
• W2033687467 creator A5030343009 @default.
• W2033687467 creator A5054565426 @default.
• W2033687467 creator A5054587936 @default.
• W2033687467 creator A5055084189 @default.
• W2033687467 creator A5055360052 @default.
• W2033687467 creator A5063911245 @default.
• W2033687467 creator A5064993872 @default.
• W2033687467 creator A5066474947 @default.
• W2033687467 creator A5070470103 @default.
• W2033687467 creator A5071214898 @default.
• W2033687467 creator A5072392490 @default.
• W2033687467 creator A5075510431 @default.
• W2033687467 creator A5076983412 @default.
• W2033687467 creator A5077488472 @default.
• W2033687467 creator A5082353604 @default.
• W2033687467 creator A5086240813 @default.
• W2033687467 creator A5090846784 @default.
• W2033687467 date "2014-04-01" @default.
• W2033687467 modified "2023-10-07" @default.
• W2033687467 title "Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Severely Stenotic Bicuspid Versus Tricuspid or Nonbicuspid Valves" @default.
• W2033687467 cites W1964724334 @default.
• W2033687467 cites W1970667076 @default.
• W2033687467 cites W2035479977 @default.
• W2033687467 cites W2057797574 @default.
• W2033687467 cites W2102129596 @default.
• W2033687467 cites W2121967184 @default.
• W2033687467 cites W2149609916 @default.
• W2033687467 cites W2153820409 @default.
• W2033687467 cites W2163674015 @default.
• W2033687467 cites W2164686231 @default.
• W2033687467 cites W2166457346 @default.
• W2033687467 cites W27658002 @default.
• W2033687467 doi "https://doi.org/10.1016/j.amjcard.2014.01.412" @default.
• W2033687467 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24581922" @default.
• W2033687467 hasPublicationYear "2014" @default.
• W2033687467 type Work @default.
• W2033687467 sameAs 2033687467 @default.
• W2033687467 citedByCount "78" @default.
• W2033687467 countsByYear W20336874672014 @default.
• W2033687467 countsByYear W20336874672015 @default.
• W2033687467 countsByYear W20336874672016 @default.
• W2033687467 countsByYear W20336874672017 @default.
• W2033687467 countsByYear W20336874672018 @default.
• W2033687467 countsByYear W20336874672019 @default.
• W2033687467 countsByYear W20336874672020 @default.
• W2033687467 countsByYear W20336874672021 @default.
• W2033687467 countsByYear W20336874672022 @default.
• W2033687467 countsByYear W20336874672023 @default.
• W2033687467 crossrefType "journal-article" @default.
• W2033687467 hasAuthorship W2033687467A5023950438 @default.
• W2033687467 hasAuthorship W2033687467A5024321268 @default.
• W2033687467 hasAuthorship W2033687467A5030343009 @default.
• W2033687467 hasAuthorship W2033687467A5054565426 @default.
• W2033687467 hasAuthorship W2033687467A5054587936 @default.
• W2033687467 hasAuthorship W2033687467A5055084189 @default.
• W2033687467 hasAuthorship W2033687467A5055360052 @default.
• W2033687467 hasAuthorship W2033687467A5063911245 @default.
• W2033687467 hasAuthorship W2033687467A5064993872 @default.
• W2033687467 hasAuthorship W2033687467A5066474947 @default.
• W2033687467 hasAuthorship W2033687467A5070470103 @default.
• W2033687467 hasAuthorship W2033687467A5071214898 @default.
• W2033687467 hasAuthorship W2033687467A5072392490 @default.
• W2033687467 hasAuthorship W2033687467A5075510431 @default.
• W2033687467 hasAuthorship W2033687467A5076983412 @default.
• W2033687467 hasAuthorship W2033687467A5077488472 @default.
• W2033687467 hasAuthorship W2033687467A5082353604 @default.
• W2033687467 hasAuthorship W2033687467A5086240813 @default.
• W2033687467 hasAuthorship W2033687467A5090846784 @default.
• W2033687467 hasConcept C126322002 @default.
• W2033687467 hasConcept C141071460 @default.
• W2033687467 hasConcept C164705383 @default.
• W2033687467 hasConcept C176752191 @default.
• W2033687467 hasConcept C2776570981 @default.
• W2033687467 hasConcept C2780007028 @default.
• W2033687467 hasConcept C2780714102 @default.
• W2033687467 hasConcept C2781355080 @default.
• W2033687467 hasConcept C2781414266 @default.
• W2033687467 hasConcept C2910672364 @default.
• W2033687467 hasConcept C71924100 @default.
• W2033687467 hasConceptScore W2033687467C126322002 @default.
• W2033687467 hasConceptScore W2033687467C141071460 @default.
• W2033687467 hasConceptScore W2033687467C164705383 @default.
• W2033687467 hasConceptScore W2033687467C176752191 @default.
• W2033687467 hasConceptScore W2033687467C2776570981 @default.
• W2033687467 hasConceptScore W2033687467C2780007028 @default.
• W2033687467 hasConceptScore W2033687467C2780714102 @default.
• W2033687467 hasConceptScore W2033687467C2781355080 @default.
• W2033687467 hasConceptScore W2033687467C2781414266 @default.
• W2033687467 hasConceptScore W2033687467C2910672364 @default.
• W2033687467 hasConceptScore W2033687467C71924100 @default.
• W2033687467 hasIssue "8" @default.
• W2033687467 hasLocation W20336874671 @default.
• W2033687467 hasLocation W20336874672 @default.
• W2033687467 hasOpenAccess W2033687467 @default.

• next